EdgarLookup

abrdn Gold ETF Trust — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that abrdn Gold ETF Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
36.2%
Return on Assets
Net income ÷ assets
0x
Debt-to-Equity
Total liabilities ÷ equity

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $464.0K Feb 28, 2014
FY2012 Dec 31, 2012 $1.48M Feb 28, 2013
FY2011 Dec 31, 2011 $1.22M Feb 29, 2012
FY2011 Dec 31, 2010 $186.5K Feb 29, 2012
FY2011 Dec 31, 2009 $20.9K Feb 29, 2012

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.65B Mar 3, 2026
FY2025 Dec 31, 2024 $710.64M Mar 3, 2026
FY2025 Dec 31, 2023 $345.74M Mar 3, 2026
FY2024 Dec 31, 2022 ($17.37M) Feb 28, 2025
FY2023 Dec 31, 2021 ($130.98M) Feb 29, 2024
FY2022 Dec 31, 2020 $363.75M Mar 1, 2023
FY2021 Dec 31, 2019 $153.68M Sep 29, 2022
FY2020 Dec 31, 2018 ($22.16M) Mar 1, 2021
FY2019 Dec 31, 2017 $106.86M Feb 28, 2020
FY2018 Dec 31, 2016 $50.02M Feb 28, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2014 Dec 31, 2012 $0 Mar 2, 2015
FY2013 Dec 31, 2011 $0 Feb 28, 2014
FY2012 Dec 31, 2010 $0 Feb 28, 2013
FY2011 Dec 31, 2009 $0 Feb 29, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.33B Mar 3, 2026
FY2025 Dec 31, 2024 $3.76B Mar 3, 2026
FY2024 Dec 31, 2023 $2.83B Feb 28, 2025
FY2023 Dec 31, 2022 $2.44B Feb 29, 2024
FY2022 Dec 31, 2021 $2.39B Mar 1, 2023
FY2021 Dec 31, 2020 $2.65B Sep 29, 2022
FY2020 Dec 31, 2019 $1.20B Mar 1, 2021
FY2019 Dec 31, 2018 $846.84M Feb 28, 2020
FY2018 Dec 31, 2017 $1.05B Feb 28, 2019
FY2017 Dec 31, 2016 $935.27M Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.06M Mar 3, 2026
FY2025 Dec 31, 2024 $548.0K Mar 3, 2026
FY2024 Dec 31, 2023 $409.0K Feb 28, 2025
FY2023 Dec 31, 2022 $346.0K Feb 29, 2024
FY2022 Dec 31, 2021 $346.0K Mar 1, 2023
FY2021 Dec 31, 2020 $379.0K Sep 29, 2022
FY2020 Dec 31, 2019 $171.0K Mar 1, 2021
FY2019 Dec 31, 2018 $119.0K Feb 28, 2020
FY2018 Dec 31, 2017 $347.0K Feb 28, 2019
FY2017 Dec 31, 2016 $316.0K Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.33B Mar 3, 2026
FY2025 Dec 31, 2024 $3.76B Mar 3, 2026
FY2025 Dec 31, 2023 $2.83B Mar 3, 2026
FY2025 Dec 31, 2022 $2.44B Mar 3, 2026
FY2024 Dec 31, 2021 $2.39B Feb 28, 2025
FY2023 Dec 31, 2020 $2.65B Feb 29, 2024
FY2022 Dec 31, 2019 $1.20B Mar 1, 2023
FY2021 Dec 31, 2018 $846.72M Sep 29, 2022
FY2020 Dec 31, 2017 $1.05B Mar 1, 2021
FY2019 Dec 31, 2016 $934.95M Feb 28, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2015 Dec 31, 2012 ($368.76M) Feb 29, 2016
FY2014 Dec 31, 2011 ($301.08M) Mar 2, 2015
FY2013 Dec 31, 2010 ($186.82M) Feb 28, 2014
FY2012 Dec 31, 2009 ($8.65M) Feb 28, 2013
FY2011 Aug 31, 2009 $0 Feb 29, 2012

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2015 Dec 31, 2012 $0 Feb 29, 2016
FY2014 Dec 31, 2011 $0 Mar 2, 2015
FY2013 Dec 31, 2010 $0 Feb 28, 2014
FY2012 Dec 31, 2009 $0 Feb 28, 2013
FY2011 Aug 31, 2009 $0 Feb 29, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 16 Mar 3, 2026
FY2025 Dec 31, 2024 4 Mar 3, 2026
FY2025 Dec 31, 2023 2 Mar 3, 2026
FY2024 Dec 31, 2022 0 Feb 28, 2025
FY2023 Dec 31, 2021 0 Feb 29, 2024
FY2022 Dec 31, 2020 2 Mar 1, 2023
FY2021 Dec 31, 2019 2 Sep 29, 2022
FY2020 Dec 31, 2018 0 Mar 1, 2021
FY2019 Dec 31, 2017 1 Feb 28, 2020
FY2018 Dec 31, 2016 6 Feb 28, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 178.60M Mar 3, 2026
FY2025 Dec 31, 2024 150.70M Mar 3, 2026
FY2024 Dec 31, 2023 142.20M Feb 28, 2025
FY2023 Dec 31, 2022 140.60M Feb 29, 2024
FY2022 Dec 31, 2021 138.00M Mar 1, 2023
FY2021 Dec 31, 2020 146.20M Sep 29, 2022
FY2020 Dec 31, 2019 82.00M Mar 1, 2021
FY2019 Dec 31, 2018 68.50M Feb 28, 2020
FY2018 Dec 31, 2017 8.35M Feb 28, 2019
FY2017 Dec 31, 2016 8.30M Feb 27, 2018